A Double-Blind, Randomized, Placebo-Controlled Phase 1 Study of Ad26.ZIKV.001, an Ad26-Vectored Anti–Zika Virus Vaccine

Annals of Internal Medicine
May 2021 Volume 174, Issue 5
http://annals.org/aim/issue

 

Original Research
A Double-Blind, Randomized, Placebo-Controlled Phase 1 Study of Ad26.ZIKV.001, an Ad26-Vectored Anti–Zika Virus Vaccine
Nadine C. Salisch, PhD, Kathryn E. Stephenson, MD, MPH, Kristi Williams, BSN, PhD, Freek Cox, PhD, … et al.
Pages:585–594